Pharmaxis Ltd
OTC: PMXSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Gary Jonathan Phillips
- Employees
- 27
- Headquarters
- Frenchs Forest, Australia
- IPO year
- 2010
- Market cap
- $31.0M
- Website
- https://www.pharmaxis.com.au
Loading PMXSF…
Loading profile data…Frequently asked questions about PMXSF
What does Pharmaxis Ltd (PMXSF) do?
Pharmaxis Ltd, an Australian biopharmaceutical company established in 1998 and headquartered in Frenchs Forest, specializes in the global research, development, and commercialization of therapeutic products for fibrotic and inflammatory diseases. Its business is organized into two main divisions: the Mannitol Respiratory Business and New Drug De...
Where does PMXSF trade?
Pharmaxis Ltd (PMXSF) trades on the Other OTC.
What sector is PMXSF in?
Pharmaxis Ltd (PMXSF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Pharmaxis Ltd?
Gary Jonathan Phillips is the chief executive officer of Pharmaxis Ltd (PMXSF).
Where is Pharmaxis Ltd headquartered?
Pharmaxis Ltd is headquartered in Australia.
Does PMXSF pay a dividend?
Pharmaxis Ltd (PMXSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PMXSF go public?
Pharmaxis Ltd (PMXSF) completed its initial public offering in 2010.